BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36031077)

  • 1. Hepatitis E Virus Infection in Cancer Patients.
    Chiu CY; Zhang HC; Westin J; Hosing C; Torres HA
    Transplant Cell Ther; 2022 Nov; 28(11):788.e1-788.e5. PubMed ID: 36031077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation.
    Versluis J; Pas SD; Agteresch HJ; de Man RA; Maaskant J; Schipper ME; Osterhaus AD; Cornelissen JJ; van der Eijk AA
    Blood; 2013 Aug; 122(6):1079-86. PubMed ID: 23794068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection.
    Furfaro E; Nicolini L; Della Vecchia A; Di Grazia C; Raiola AM; Varaldo R; Ferrando F; Barisione G; Bruzzone B; Angelucci E; Viscoli C; Mikulska M
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1355-1362. PubMed ID: 32200124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study.
    Franz A; Reuken PA; Guliyeva S; Rose M; Boden K; Stallmach A; Bruns T
    J Int Med Res; 2023 Jul; 51(7):3000605231187941. PubMed ID: 37523153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
    Carter M; Solsrud K; Yeddula S; Fitzmaurice MG; Singh A; Nagai S; Jafri SM
    Transplant Proc; 2022 Sep; 54(7):1737-1741. PubMed ID: 35907694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States.
    Koning L; Charlton MR; Pas SD; Heimbach JK; Osterhaus AD; Watt KD; Janssen HL; de Knegt RJ; van der Eijk AA
    BMC Infect Dis; 2015 Sep; 15():371. PubMed ID: 26328802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
    Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
    J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
    Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
    Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.
    Affeldt P; Di Cristanziano V; Grundmann F; Wirtz M; Kaiser R; Benzing T; Stippel D; Kann M; Kurschat C
    Immun Inflamm Dis; 2021 Jun; 9(2):513-520. PubMed ID: 33559399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.
    Swartling L; Nordén R; Samuelsson E; Boriskina K; Valentini D; Westin J; Norder H; Sparrelid E; Ljungman P
    Bone Marrow Transplant; 2020 Jul; 55(7):1255-1263. PubMed ID: 32071417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
    Tavitian S; Peron JM; Huguet F; Kamar N; Abravanel F; Beyne-Rauzy O; Oberic L; Faguer S; Alric L; Roussel M; Gaudin C; Ysebaert L; Huynh A; Recher C
    Emerg Infect Dis; 2015 Aug; 21(8):1466-9. PubMed ID: 26197210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection.
    van de Garde MD; Pas SD; van der Net G; de Man RA; Osterhaus AD; Haagmans BL; Boonstra A; Vanwolleghem T
    J Virol; 2016 May; 90(9):4394-401. PubMed ID: 26889028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient.
    Chen Z; Wei J; Jiang L; Ying D; Tian W; Zhang M; Wen G; Wang S; Liu C; Wang Y; Wu T; Tang Z; Zheng Z; Yan L; Xia N
    Front Immunol; 2022; 13():954697. PubMed ID: 36275730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.
    Ying D; Niu W; Chen Y; Wang Y; Tian W; Zhang X; Liu C; Wang S; Chen Z; Lin Y; Guo S; Yu Z; Chen X; Fang M; Qiang H; Yin Y; Tang Z; Zheng Z; Fu L; Xia N
    Front Immunol; 2023; 14():1183859. PubMed ID: 37404820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.
    Ankcorn MJ; Ijaz S; Poh J; Elsharkawy AM; Smit E; Cramb R; Ravi S; Martin K; Tedder R; Neuberger J
    Transplantation; 2018 Jul; 102(7):1139-1147. PubMed ID: 29953421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.